Pharmacogenomic, Physiological, and Biochemical Investigations on Safety and Efficacy Biomarkers Associated with the Peroxisome Proliferator-Activated Receptor-γ Activator Rosiglitazone in Rodents: A Translational Medicine Investigation
Xinkang Wang(Bristol-Myers Squibb (Germany)), Giora Feuerstein(New Frontier), Xin Xu(Beijing University of Chemical Technology), Zaid Abassi(Technion – Israel Institute of Technology), J. Lynn Rutkowski, Liz Diblasio-Smith, Lisa A. Collins‐Racie, Joseph Winaver(Technion – Israel Institute of Technology), Xiaorong Liu(Hunan University of Traditional Chinese Medicine), William Mounts(Pfizer (United States)), Edward R. LaVallie(Boston University), Yutian Zhan(Pfizer (United States)), Ilia Goltsman
Cited by 15
Related Papers
Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations
|Stroke|2009|1.3k
A phase I/IItrial of MYO‐029 in adult subjects with muscular dystrophy
|Annals of Neurology|2008|466
Caspase-8 and Caspase-3 Are Expressed by Different Populations of Cortical Neurons Undergoing Delayed Cell Death after Focal Stroke in the Rat
|Journal of Neuroscience|1999|270
GWASdb: a database for human genetic variants identified by genome-wide association studies
|Nucleic Acids Research|2011|233
Crystal structures of the two major aggrecan degrading enzymes, ADAMTS4 and ADAMTS5
|Protein Science|2007|142